Search results

The Oversupply dashboard is now available in ePACT2.   Oversupply is when more medication is dispensed than is typically needed or wanted by the patient. This dashboard will support improvement initiatives, particularly around addressing…

Real Time Exemption Checking (RTEC) is designed to streamline the process for patients and pharmacy teams by improving how exemption categories are recorded.  The NHSBSA reporting of RTEC exemptions has been restricted due to system supplier issues…

Prescription data for items prescribed in England and dispensed in Scotland from June 2023 to June 2024 is not held in ePACT2. From July onwards the data feed into ePACT2 should have been restored.  The missing Scottish dispensing data can be found…

Secondary Care Medicines Data (SCMD) is published by the NHSBSA on behalf of NHS England. It contains processed pharmacy stock control data in a standardised format from all NHS Acute, Teaching, Specialist, Mental Health, and Community Trusts in…

NHS RightCare have shared the latest Similar 10 profiles with the NHSBSA. This data will allow users to compare similar Sub Integrated Care Board Locations (SICBL) based on their population and demographics.   We will refresh our dashboards to…

Contractors should note the minimum number of Pharmacy First Clinical Pathway consultations required to be delivered to secure the monthly fixed payment has changed from November 2024.   The following thresholds have been agreed: November – 20…

This accessibility statement applies to the online report: Healthcare inequalities – NHS Prescribing of Hormone Replacement Therapy to treat symptoms of the Menopause. This website is run by the NHS Business Services Authority (NHSBSA). We want as…

The NHS Business Services Authority (NHSBSA) is a forward thinking, innovative organisation. We help the NHS to run efficiently by providing platforms, and delivering services that support the priorities of the NHS, government, and local health…

Combatting antimicrobial resistance, the UK’s second five-year national action plan promotes optimal use of antimicrobials in humans to ensure safe, effective care by strengthening antimicrobial stewardship programmes. It aims to reduce UK…

Combatting antimicrobial resistance, the UK’s second five-year national action plan continues to promote optimal use of antimicrobials in humans to ensure safe and effective patient care by strengthening antimicrobial stewardship programmes. There…